Exploratory survey study of long-term users of nicotine replacement therapy in Danish consumers

Harm Reduction Journal

Volumn 12, Issue 1, 2015, Pages

  Borup, Gitte ^a   Mikkelsen, Kim Lyngby ^b   Tønnesen, Philip ^c   Christrup, Lona Louring ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b The Danish Patient Compensation Association   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Long term use; Modified Heaviness of Smoking Index; Nicotine dependence; Nicotine replacement therapy; NRT; Survey research; User perspective

Indexed keywords

NICOTINE; NICOTINE GUM;

ADULT; AGED; ARTICLE; CONSUMER; DANISH CITIZEN; FEAR; FEMALE; HEALTH CARE COST; HEALTH STATUS; HEALTH SURVEY; HEAVINESS OF SMOKING INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; QUESTIONNAIRE; SCORING SYSTEM; TOBACCO DEPENDENCE; CONSUMER ATTITUDE; DENMARK; MIDDLE AGED; MOTIVATION; PROCEDURES; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; TIME; TOBACCO USE DISORDER;

ADULT; AGED; CONSUMER BEHAVIOR; DENMARK; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MOTIVATION; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; TIME; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84938701021     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-12-2     Document Type: Article

References (39)

1. Danskernes Rygevaner [ http://sundhedsstyrelsen.dk/da/sundhed/tobak/tal-og-undersoegelser/danskernes-rygevaner/2012 ] []
2. Sims TH, Fiore MC: Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy? CNS Drugs 2002,16(10):653-662. 10.2165/00023210-200216100-00001
3. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P: Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 2009, 338: b1024. 10.1136/bmj.b1024
4. Etter JF: Dependence on the nicotine gum in former smokers. Addict Behav 2009,34(3):246-251. 10.1016/j.addbeh.2008.10.018
5. Hajek P, McRobbie H, Gillison F: Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user. Prev Med 2007,44(3):230-234. 10.1016/j.ypmed.2006.10.005
6. Hughes JR, Gust SW, Keenan R, Fenwick JW, Skoog K, Higgins ST: Long-term use of nicotine vs placebo gum. Arch Intern Med 1991,151(10):1993-1998. 10.1001/archinte.1991.00400100073012
7. Tonnesen P, Mikkelsen K: Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial. Nicotine Tob Res 2013,15(2):419-427. 10.1093/ntr/nts146
8. Shiffman S, Hughes JR, Di Marino ME, Sweeney CT: Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking. Addiction 2003,98(12):1747-1753. 10.1111/j.1360-0443.2003.00575.x
9. Garvey AJ, Kinnunen T, Nordstrom BL, Utman CH, Doherty K, Rosner B, Vokonas PS: Effects of nicotine gum dose by level of nicotine dependence. Nicotine Tob Res 2000,2(1):53-63. 10.1080/14622200050011303
10. Hajek P, Jackson P, Belcher M: Long-term use of nicotine chewing gum. Occurrence, determinants, and effect on weight gain. JAMA 1988,260(11):1593-1596. 10.1001/jama.1988.03410110101035
11. Jarvis MJ, Raw M, Russell MA, Feyerabend C: Randomised controlled trial of nicotine chewing-gum. BMJ 1982,285(6341):537-540. 10.1136/bmj.285.6341.537
12. Tonnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, Stockner M: Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 1988,318(1):15-18. 10.1056/NEJM198801073180104
13. Shiffman S, Sweeney CT: Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability? Health Policy 2008,86(1):17-26. 10.1016/j.healthpol.2007.08.006
14. Benowitz NL, Gourlay SG: Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997,29(7):1422-1431. 10.1016/S0735-1097(97)00079-X
15. Eliasson B, Taskinen MR, Smith U: Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996,94(5):878-881. 10.1161/01.CIR.94.5.878
16. Assali AR, Beigel Y, Schreibman R, Shafer Z, Fainaru M: Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol 1999,22(5):357-360. 10.1002/clc.4960220512
17. Moffatt RJ, Biggerstaff KD, Stamford BA: Effects of the transdermal nicotine patch on normalization of HDL-C and its subfractions. Prev Med 2000,31(2 Pt 1):148-152.
18. Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO: Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis 2010, 8: 8-9625-8-8.
19. Gray N: The ethics of policies for the prevention of tobacco disease. Acta Oncologica (Stockholm, Sweden) 2004,43(1):8-10. 10.1080/02841860310017937
20. Hajek P: What limits the efficacy of current nicotine replacement therapies? Edited by: Novartis Foundation G, Bock J, Goode J. Chichester, UK: John Wiley & Sons, Ltd; 2008:204-218.
21. Le Houezec J, Aubin HJ: Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence. Expert Opin Pharmacother 2013,14(14):1959-1967. 10.1517/14656566.2013.818978
22. Taylor CR, Capella ML: Smokeless tobacco products as a harm-reduction mechanism: a research agenda. Fal 2008,27(2):187-196.
23. Black A, Beard E, Brown J, Fidler J, West R: Beliefs about the harms of long-term use of nicotine replacement therapy: perceptions of smokers in England. Addiction 2012,107(11):2037-2042. 10.1111/j.1360-0443.2012.03955.x
24. Borland R, Li L, Mortimer K, McNeil A, King B, O'Connor RJ: The acceptability of nicotine containing products as alternatives to cigarettes: findings from two pilot studies. Harm Reduct J 2011, 8: 27-7517-8-27.
25. Shiffman S, Hughes JR, Ferguson SG, Pillitteri JL, Gitchell JG, Burton SL: Smokers' interest in using nicotine replacement to aid smoking reduction. Nicotine Tob Res 2007,9(11):1177-1182. 10.1080/14622200701648441
26. Klesges RC, Klesges LM, Vander Weg MW, DeBon M, Poston WS, Ebbert J, Hays JT, Haddock CK: Characteristics of Air Force personnel who choose pharmacological aids for smoking cessation following an involuntary tobacco ban and tobacco control program. Health Psychol 2007,26(5):588-597.
27. Jimenez-Ruiz C, Solano S, Viteri SA, Ferrero MB, Torrecilla M, Mezquita MH: Harm reduction-a treatment approach for resistant smokers with tobacco-related symptoms. Respiration 2002,69(5):452-455. 10.1159/000064015
28. O'Connor RJ, Norton KJ, Bansal-Travers M, Mahoney MC, Cummings KM, Borland R: US smokers' reactions to a brief trial of oral nicotine products. Harm Reduct J 2011,8(1):1. 1-7517-8-1 1-7517-8-1 10.1186/1477-7517-8-1
29. Timberlake DS: Are smokers receptive to using smokeless tobacco as a substitute? Prev Med 2009,49(2-3):229-232.
30. Borup G: Survey questionnaire. 01-14. 2013. Available at: https://www.survey-xact.dk/LinkCollector?key=J126DX5X1NC5 Available at:
31. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T: Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend 1994,34(3):211-216. 10.1016/0376-8716(94)90158-9
32. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J: Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989,84(7):791-799. 10.1111/j.1360-0443.1989.tb03059.x
33. Agrawal A, Scherrer JF, Pergadia ML, Lynskey MT, Madden PA, Sartor CE, Grant JD, Duncan AE, Haber JR, Jacob T, Bucholz KK, Xian H: A latent class analysis of DSM-IV and Fagerstrom (FTND) criteria for nicotine dependence. Nicotine Tob Res 2011,13(10):972-981. 10.1093/ntr/ntr105
34. Baker TB, Piper ME, McCarthy DE, Bolt DM, Smith SS, Kim SY, Colby S, Conti D, Giovino GA, Hatsukami D, Hyland A, Krishnan-Sarin S, Niaura R, Perkins KA, Toll BA: Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res 2007,9(Suppl 4):S555-S570.
35. Chaiton MO, Cohen JE, McDonald PW, Bondy SJ: The Heaviness of Smoking Index as a predictor of smoking cessation in Canada. Addict Behav 2007,32(5):1031-1042. 10.1016/j.addbeh.2006.07.008
36. Ybarra ML, Suman M: Help seeking behavior and the Internet: a national survey. Int J Med Inform 2006,75(1):29-41. 10.1016/j.ijmedinf.2005.07.029
37. Glümer C, Hilding-Nørkjær H, Jensen HN, Jørgensen T, Andreasen AH, Ladelund S: Sundhedsprofil for region og kommuner 2008. Glostrup: Region Hovedstaden; 2008.
38. Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Kitchens K, Van Vunakis H: The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal? J Consult Clin Psychol 1995,63(3):388-399.
39. Murray RP, Bailey WC, Daniels K, Bjornson WM, Kurnow K, Connett JE, Nides MA, Kiley JP: Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Res Group Chest 1996,109(2):438-445.